Roivant Sciences Ltd at JPMorgan Healthcare Conference Transcript
Good afternoon. Thanks for joining us for another session at the 42nd JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. I'm joined by my associate Sean Kim, who is in the audience today.
On stage, we have Roivant's CEO, Matt Gline. I'll pass the mic to Matt shortly for a presentation followed by a live audience Q&A. If you're joining us live here in the audience today, you can submit the questions for the team through our conference portal or you can hold your hands up during the Q&A session. I'll pass this to Matt. Matt, the stage is yours.
Thank you. Good afternoon. Thanks for coming today. It's good to see some familiar faces, some new ones. It's a pleasure to be here. So I'm going to go through just a brief presentation. And then as Brian said, we'll hang out and answer some questions (inaudible). So I'm going to be making some forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
